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Gene expressionMany viruses activate the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway, thereby modulating
diverse downstream signaling pathways associated with antiapoptosis, proliferation, cell cycling, protein
synthesis and glucose metabolism, in order to augment their replication. To date, the role of the PI3K-Akt
pathway in Baculovirus replication has not been deﬁned. In the present study, we demonstrate that infection
of Sf9 cells with Autographa californica multiple nucleopolyhedrovirus (AcMNPV) elevated cellular Akt
phosphorylation at 1 h post-infection. The maximum Akt phosphorylation occurred at 6 h post-infection and
remained unchanged until 18 h post-infection. The PI3K-speciﬁc inhibitor, LY294002, suppressed Akt
phosphorylation in a dose-dependent manner, suggesting that AcMNPV-induced Akt phosphorylation is
PI3K-dependent. The inhibition of PI3K-Akt activation by LY294002 signiﬁcantly reduced the viral yield,
including a reduction in budded viruses and occlusion bodies. The virus production was reduced only when
the inhibitor was added within 24 h of infection, implying that activation of PI3K occurred early in infection.
Correspondingly, both viral DNA replication and late (VP39) and very late (POLH) viral protein expression
were impaired by LY294002 treatment; LY294002 had no effect on immediate-early (IE1) and early-late
(GP64) protein expression. These results demonstrate that the PI3K-Akt pathway is required for efﬁcient
Baculovirus replication.© 2009 Elsevier Inc. All rights reserved.IntroductionBaculoviridae is a diverse family of pathogens that infects
arthropods. These viruses have been detected worldwide in over
600 host species, predominantly from insects of the order Lepidoptera
but also from the orders Diptera and Hymenoptera (Rohrmann, 2008).
Baculoviruses contain a large, circular, double-stranded DNA genome
(ranging from 80 to 180 kbp) within a rod-shaped capsid that is
enclosed within a lipid envelope (Theilmann et al., 2005). The
prototype virus of Baculoviridae, Autographa californica multiple
nucleopolyhedrovirus (AcMNPV), produce two types of virions during
the infection cycle. This results in efﬁcient viral replication within
infected insect larvae and insect-to-insect viral spread in nature.
Occlusion-derived viruses, located within occlusion bodies (OBs), are
transmitted from insect to insect via oral infection. Budded viruses
(BVs) are produced from infected midgut epithelial cells and can
initiate a secondary infection (Federici, 1997).
Recent work has shown that many viruses are able to modulate
cellular events, particularly those governing apoptosis and cellular
survival, thereby allowing efﬁcient replication and progeny produc-
tion (Ji and Liu, 2008;Cooray, 2007). The phosphatidylinositol 3-.
ll rights reserved.kinase (PI3K)-Akt signaling pathway plays an important role in cell
survival, apoptosis, proliferation, migration, differentiation, and
metabolic regulation. Recently, an increasing number of studies have
demonstrated that many viruses can activate the PI3K-Akt signaling
pathway. For example, Akt (also known as protein kinase B)
phosphorylation is elevated in the late phase of inﬂuenza A/PR/8/
34 infection in human lung carcinoma cells, and inhibition of PI3K-Akt
activation by LY294002, a PI3K inhibitor, results in reduced viral RNA
synthesis, viral protein expression, and viral yield (Shin et al., 2007).
PI3K consists of a regulatory subunit (p85) and a catalytic subunit
(p110) and exhibits both protein kinase and lipid kinase activities
(Nurnberg, 2003; Dhand et al., 1994). Studies in mammalian cells
have demonstrated that PI3K is activated by many different
mitogenic signals (e.g., epidermal growth factor) (Stoyanov et al.,
1995). Activated PI3K preferentially phosphorylates the membrane
phospholipid, phosphatidylinositol (4, 5)-biphosphate, to produce
phosphatidylinositol (3, 4, 5)-triphosphate. Phosphatidylinositol (3, 4,
5)-triphosphate functions as a second messenger to recruit pleckstrin
homology domain-containing proteins, such as Akt and phosphoinosi-
tide-dependent kinase 1. Akt is a cytoplasmic serine/threonine kinase
and a major PI3K effector. Activation of Akt is mediated by
phosphorylation of both serine 473 (Ser 473) and threonine 308 (Thr
308) residues through either a PI3K-dependent or -independent
mechanism (Meier et al., 1997; Welch et al., 1998). Phosphorylated
Akt plays a central role in modulating diverse downstream signaling
Fig. 1. AcMNPV infection of Sf9 cells activates Akt phosphorylation in a PI3K-dependent
manner. (A) Serum-starved Sf9 cells were infected with AcMNPV or mock-infected. Cell
lysates isolated at the designated time points pi were subjected toWestern blot analysis
using a phospho-Akt (Ser 473)- or total Akt-speciﬁc antibody (upper and lower panel,
respectively). (B) Serum-starved Sf9 cells were treated with different doses of
LY294002 for 1 h prior to infection with AcMNPV. Cell lysates were prepared at 6 hpi
and were subjected to Western blot analysis using a phospho-Akt (Ser 473)- or total
Akt-speciﬁc antibody (upper and lower panel, respectively). (C) Band density in B
(upper panel) was quantiﬁed by using Quantity One analysis software (Bio-Rad).
Statistical analysis was performed with Student's t tests. ⁎, Pb0.05 compared to
LY294002-untreated infected cells. Error bars represent the standard deviation. Similar
results were obtained in three independent experiments.
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1995; Datta et al., 1999).
Virtually all mammalian viruses, both DNA and RNA, must regulate
this pathway, either by activating or inactivating some aspects of it
(Buchkovich et al., 2008). Besides the inﬂuenza A/PR/8/34 as above
mentioned, the PI3K-Akt pathway is required for efﬁcient replication
of both human Cytomegalovirus (Johnson et al., 2001) and coxsack-
ievirus B3 (Esfandiarei et al., 2004). In contrast, Guo (Guo et al., 2007)
has shown that the expression of PI3K can inhibit hepatitis B virus
RNA transcription and reduce hepatitis B virus DNA replication in
HepG2 cells. These data suggest that activation of the PI3K-Akt
pathway may be at least partially responsible for the elimination of
hepatitis B virus replication.
However, the requirement for cell signaling in Baculovirus
replication is unknown. In the present study, we investigated the
role of the PI3K-Akt signaling pathway in the replication of AcMNPV.
Our ﬁndings demonstrate that Akt is activated immediately following
infection of Sf9 cells with AcMNPV in a PI3K-dependent manner, and
the level of activated Akt is sustained throughout the course of
infection. Inhibition of the PI3K-Akt pathway with a speciﬁc inhibitor,
LY294002, dramatically decreased BV and OB production, viral DNA
synthesis, and the protein expression of late and very late viral genes.
Therefore, we demonstrate for the ﬁrst time that the PI3K-Akt
pathway is essential for efﬁcient AcMNPV propagation.
Results
AcMNPV infection leads to activation of Akt
The major PI3K effector, Akt, is phosphorylated when the PI3K-Akt
pathway is activated; therefore, we measured the level of Akt
phosphorylation to determine whether AcMNPV infection could
activate this pathway. Serum-starved Sf9 cells were infected with
AcMNPV or mock-infected. The AcMNPV stock was harvested from
infected Sf9 cells maintained in 10% fetal bovine serum (FBS)-
containing media at 72 h post-infection (pi), and the virus inoculum
was prepared by diluting the viral stock (about 60 times in our hands)
withmedia lacking FBS. Because the virus inoculummay contain some
trace of FBS, the mock inoculumwas prepared as the above procedure
but the cells were not infected with AcMNPV.
A Western blot was performed on cell lysates generated at the
indicated time points pi. Akt phosphorylation was measured using an
antibody that only recognizes Akt phosphorylated on Ser 473. As
shown in Fig. 1A (upper panel), the level of phosphorylated Akt in
AcMNPV-infected Sf9 cells at 0, 15, and 30 min pi did not change
signiﬁcantly compared to the mock-infected cells. At 1 hpi, however,
the amount of phosphorylated Akt increased, reaching a maximum
level at 6 hpi that remained maximum until 18 hpi. A Western blot
using an antibody recognizing total Akt demonstrated that the
amount of total Akt protein remained stable throughout infection
(Fig. 1A, lower panel). This result indicated that the upregulation of
Akt phosphorylationwas not due to an upregulation of total Akt levels.
These results clearly show that AcMNPV infection induces Akt
phosphorylation in Sf9 cells.
Akt can be activated in cells by either PI3K-dependent or -
independent mechanisms (Filippa et al., 1999; Kandel and Hay, 1999).
To determine whether the AcMNPV-induced phosphorylation of Akt
was dependent upon PI3K activity, LY294002, a speciﬁc PI3K inhibitor,
was used. LY294002 inhibits PI3K activity via competitive inhibition of
the PI3K ATP-binding site; however, it does not affect other ATP-
requiring enzymes (Vlahos et al., 1994; Galetic et al., 1999). Serum-
starved Sf9 cells were treated with increasing doses of LY294002 (5 to
20 μM) during AcMNPV infection. Cell lysates were generated at 6 hpi
and subjected to Western blot analysis to assess the phosphorylation
of Akt. As shown in the upper panel of Figs. 1B and C, when LY294002
was added during the infection, Akt phosphorylation levels decreasedin a dose-dependent manner: treatment with 10 μM and 20 μM
LY294002 restored the level of Akt phosphorylation to a level similar
to the mock-infected cells. In contrast, a high level of phosphorylated
Akt was detected at 6 hpi in untreated AcMNPV-infected Sf9 cells.
Similarly, the levels of total Akt protein remained unchanged
throughout infection (Fig. 1B, lower panel), indicating that the
changes in Akt phosphorylation were not due to changes in the total
Akt levels. These data suggest that the AcMNPV-induced Akt
phosphorylation in Sf9 cells is PI3K-dependent.
There is a basal level of phosphorylated Akt in mock-infected cells,
but the levels of phosphorylated Akt did not change at any time point
(Fig. 1A, upper panel and data not shown), suggesting that Akt
phosphorylation in infected cells is not a result of cell manipulation,
but a result of AcMNPV infection. Moreover, if AcMNPV-infected cells
were treated with 25 μM or higher concentration of LY294002, many
cells underwent apoptosis or necrosis (data not shown). When
AcMNPV-infected cells were treated with 200 μM of LY294002, about
80% cells die. However, the basal Akt phosphorylationwas still present
(data not shown). This suggested that the basal level of Akt
phosphorylation in the AcMNPV-infected cells is not PI3K-dependent.
A previous study demonstrated that in phorbol 12-myristate 13-
acetate-induced B cell chronic lymphocytic leukemia cells, the
phosphorylation of Akt was not inhibited by LY294002 and the basal
Akt phosphorylation in some samples was PI3K-independent (Barra-
gán et al., 2006).
LY294002 reduces BV and OB production in AcMNPV-infected cells
As shown above, AcMNPV infection of Sf9 cells induced the
phosphorylation of Akt in a PI3K-dependent manner. As the activated
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and Roizman, 2006; Francois and Klotman, 2003; Ehrhardt et al., 2006;
Shin et al., 2007), we determined whether inhibition of the PI3K-Akt
pathway had any effect on the AcMNPV life cycle. BV and OB production
were analyzed in Sf9 cells treated with LY294002 1 h prior to infection
with AcMNPV. BV production was determined at indicated time points
pi using a TCID50 end point dilution assay on Sf9 cells. As shown in
Fig. 2A, LY294002 signiﬁcantly reduced BV production in AcMNPV-Fig. 2. Effect of LY294002 on BV and OB production in AcMNPV-infected Sf9 cells. Serum-sta
infection and were infected with AcMNPV. At the indicated time points pi, the BV produc
production (B) was quantiﬁed using a hemocytometer. BV (C) and OB (D) production after a
with 20 μM LY294002 or mock-treated at different time points preinfection or pi with AcMN
LY294002 on BV (E) and OB (F) production in AcMNPV-infected Sf9 cells. Serum-starved Sf9 c
72 hpi, BV and OB production were quantiﬁed as described above. (G) Effect of LY294002 o
viabilities were assessed by trypan blue staining assay. Data were expressed as a percentage
Statistical analysis was performed with Student's t tests. ⁎, Pb0.05 compared to LY294002-infected Sf9 cells: BV production in untreated Sf9 cells was 3.9, 3.9, 3.9
and 2.6-fold greater than BV production in LY294002-treated cells at 24,
48, 72 and 96 hpi. The effect of LY294002 on OB production is shown in
Fig. 2B. OB production in LY294002-treated cells was strongly reduced
compared to untreated samples: OB production in untreated Sf9 cells
was 5.5 and 1.3 -fold greater than OB production in LY294002-treated
cells at 72 and 96 hpi. These results indicate that AcMNPV replication in
Sf9 cells is signiﬁcantly affected by LY294002, which implies that therved Sf9 cells were pretreated with 20 μM of LY294002 or mock-treated for 1 h prior to
tion (A) was quantiﬁed using a TCID50 end point dilution assay on Sf9 cells, and OB
pplication of LY294002 at different time points pi. serum-starved Sf9 cells were treated
PV. At 72 hpi, BV and OB production was quantiﬁed as described above. Dose–effect of
ells were treated with 5 to 20 μMof LY294002 for 1 h prior to infectionwith AcMNPV. At
n cell viability. Sf9 cells were incubated with different doses of LY294002. At 96 h, cell
of blue-excluded cells. Data shown are the average of three independent experiments.
untreated infected or no infected cells. Error bars represent the standard deviation.
Fig. 3. Slot blot analysis of viral DNA replication. (A) Slot blot analysis of viral DNA
replication in AcMNPV-infected Sf9 cells. Serum-starved Sf9 cells were treated with
20 μM LY294002 or mock-treated and infected with AcMNPV. At the indicated time
points pi, cells were harvested, and DNAwas isolated and applied to a nylon membrane
using a slot blot apparatus. Wild-type AcMNPV genomic DNA labeled with digoxin was
used as a probe. (B) Quantitative analysis of viral DNA replication detected in the slot
blot. Hybridization was quantiﬁed with Quantity One analysis software (Bio-Rad), and
each point represents the average from three independent experiments. Statistical
analysis was performed with Student's t tests. ⁎, Pb0.05 compared to LY294002-
untreated infected cells. Error bars represent the standard deviation.
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efﬁcient production of BVs and OBs.
To identify the stage of AcMNPV replicationwhen PI3K is activated,
we assayed BV and OB production after adding the inhibitor at
different time points pi. As shown in Figs. 2C and D, LY294002
treatment, either at 1 h prior to infection or at 2 hpi, caused a
signiﬁcant reduction in BV (74.2% reduction) and OB (82.0% reduc-
tion) production. When LY294002 was added at 8 or at 12 hpi, BV
(50.1% and 33.4% reduction, respectively) and OB (59.0% and 43.7%
reduction, respectively) production were also reduced, albeit to a
lesser degree. When LY294002 was added at 24 hpi, neither BV nor OB
production was affected. These results indicate that inhibition of BV
and OB production by LY294002 treatment occurs before 24 hpi,
suggesting that the activation of PI3K-Akt pathway or accumulation of
activated Akt at the early stage of viral infection plays an important
role in the efﬁcient replication of AcMNPV in Sf9 cells.
To demonstrate a dose-dependent effect of LY294002 on BV and
OB production, different concentrations of LY294002 (5 to 20 μM)
were tested during infection with AcMNPV. Figs. 2E and F show that
BV and OB productionwere reduced with increasing concentrations of
LY294002. This suggests that the inhibition of PI3K with LY294002
leads to a dose-dependent decrease of BV and OB production.
One possible explanation for the observed effect is that the
LY294002 is toxic to the Sf9 cells. Therefore, in order to rule this out,
dose–response studies were initially carried out. Serum-starved Sf9
cells were treated with LY294002 (5 to 25 μM) for 96 h. The cells were
assayed for viability by trypan blue staining, and the viability of 5 to
20 μM of LY294002-treated cells was comparable to that of untreated
cells. However, when 25 μM LY294002 was used, 22.7% of cells
underwent death (Fig. 2G).
Inactivation of the PI3K-Akt pathway impairs viral DNA synthesis
To determine whether viral DNA replication is blocked upon
LY294002 treatment, a slot blot analysis was carried out to examine
the viral DNA content in cells. DNA from AcMNPV-infected Sf9 cells
treated with LY294002 or mock-treated was isolated and immobilized
on nitrocellulose ﬁlters. A digoxin-labeled wild-type AcMNPV geno-
mic DNA hybridization probe was then hybridized to the ﬁlters
(Fig. 3A), and the amountof viral DNAwas quantiﬁed bymeasuring the
relative intensity (Fig. 3B). At 2 hpi, a similar amount of viral DNAwas
detected in cells treated with LY294002 or mock-treated, suggesting
that the amountof viral DNA that had entered into Sf9 cellswas similar.
The onset of viral DNA replication in untreated Sf9 cells had occurred at
12 hpi; in contrast, viral DNA replication in LY294002-treated Sf9 cells
showed a delayed onset, but had occurred at 24 hpi. The amount of
viral DNA in LY294002-treated Sf9 cells was 43.4%, 67.8%, 77.2% and
87.2% of that in untreated Sf9 cells at 12, 24, 48 and 72 hpi, respectively.
At 96 hpi, however, the amount of the viral DNA in LY294002-treated
Sf9 cells was slightly lower than that in untreated Sf9 cells. These
results demonstrate that viral DNA replication is affected in LY294002-
treated, AcMNPV-infected Sf9 cells, suggesting that the PI3K-Akt
pathway plays an important role in viral DNA replication.
Inactivation of the PI3K-Akt pathway inhibits viral late and very late
gene expression
The life cycle of AcMNPV is temporally regulated, and successive
stages of viral replication are dependent upon the proper expression of
genes during the preceding stage (Friesen, 1997). Baculovirus late and
very late gene expression is dependent upon replication of the viral
genome(Lu andMiller,1997). To further characterize the role of the PI3K-
Aktpathway inAcMNPVreplication,weexamined theeffectof LY294002
on the expression of AcMNPV genes. Sf9 cells were treated with
LY294002 or mock-treated and infected with AcMNPV. At various
times pi, whole cell lysates were generated from infected cells andsubjected to Western blot analysis with the indicated antibodies. For
these analyses, IE1-, GP64-, VP39-, and polyhedrin (POLH)-speciﬁc
antibodies were used to monitor immediate-early, early-late, late, and
very late gene expression, respectively. As shown in Fig. 4, therewere no
obvious differences in either the amountor onset of expression of the IE1
and GP64 proteins between LY294002-treated and untreated cells. In
several experiments, the apparentdifference ingp64 expression at 96hpi
was not reproducible. This suggests that LY294002 had no inhibitory
effect on the expression of the immediate-early (ie1) and early-late
(gp64) genes. In contrast, VP39 and POLH expression were both clearly
reduced in LY294002-treated cells compared to the untreated cells.
Interestingly, the inhibition of POLH expressionwasmore profound than
the inhibition of VP39 expression. The inhibition of POLH synthesis was
consistent with the reduced OB production in LY294002-treated cells
compared to untreated cells (Fig. 2B). These results suggest that
LY294002 reduced the expression of both viral late (VP39) and very
late (POLH) proteins in AcMNPV-infected Sf9 cells but did not inhibit the
level of viral immediate-early (IE1) and early-late (GP64) proteins.
Discussion
Previous studies have demonstrated that a number of viruses
activate cellular signaling pathways to augment virus production
Fig. 4. Effect of LY294002 on AcMNPV gene expression. Serum-starved Sf9 cells were
treated with 20 μM LY294002 or mock-treated and infected with AcMNPV. Cell lysates
were prepared at the indicated time points and subjected toWestern blot analysis using
antibodies against IE1 (immediate-early), GP64 (early-late), VP39 (late), or POLH (very
late). Similar results were obtained in three independent experiments.
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of cell signaling in the replication of invertebrate viruses (e.g. Bacu-
lovirus) are limited. One report has shown that Bombyx mori nu-
cleopolyhedrovirus infection upregulated the mitogen-activated
protein kinase signaling pathways, and this activation was required
for efﬁcient infection (Katsuma et al., 2007). In this study, we
demonstrate, for the ﬁrst time, that the PI3K-Akt signal transduction
pathway plays an important role in efﬁcient AcMNPV replication.
Infection of Sf9 cells with AcMNPV activated the PI3K-Akt signaling
pathway, as demonstrated by an increase in the phosphorylation of
Akt. AcMNPV infection resulted in Akt phosphorylation within 1 hpi.
This phosphorylation reached a maximum level by 6 hpi and was
sustained throughout the remainder of the infection (Fig. 1A, upper
panel). In order to better determine the function of the PI3K-Akt
pathway in AcMNPV replication, a speciﬁc PI3K inhibitor (LY294002)
was used in the present study. Akt phosphorylation was abrogated by
LY294002, suggesting that AcMNPV-induced Akt phosphorylation is
PI3K-dependent (Fig. 1B, upper panel).
We next examined whether the PI3K-Akt pathway plays a role in
BV and OB production by inhibiting PI3K activity with LY294002. We
found that LY294002 treatment signiﬁcantly reduced BV and OB
production in AcMNPV-infected Sf9 cells at various time points of pi.
Virtually almost all mammalian viruses activate this pathway at some
point in their life cycle in order to beneﬁt from the growth, metabolic,
antiapoptotic, and translational functions that the pathway regulates
(Cooray, 2004). Our result is consistent with the above observation.
Furthermore, we demonstrate that the PI3K-Akt signaling pathway
plays a beneﬁcial role in Baculovirus replication in invertebrate hosts.
Because the growth factors in serum may activate the PI3K-Akt
signaling pathway, all of the assays in the present study were done in
the absence of serum. This calls into question whether the PI3K
signaling pathway is still important in a normal infection inwhich the
cells are maintained using serum-containing media or immersed in
the hemolymph of insects and would be exposed to growth factors.
Further investigation is needed to determine whether the PI3K-Akt
signaling pathway is still important in a normal, in vivo infection, or
whether there may be other pathways that are more important.
To deﬁne the stage of viral replication that was affected, we treated
cells with LY294002 at 1 h prior to infection or 2, 8, 12 or 24 hpi. BV
and OB productionwere reduced to different degrees at different time
points.When LY294002 was added either pre-infection or at 2 hpi, the
inhibitory effect on BV and OB production was similar. This suggests
that LY294002 did not affect viral entry and that the PI3K-Akt pathway
was activated post-viral entry. This hypothesis is supported by the
observation that Akt was activated at 1 hpi (Fig. 1A). Importantly,
when the inhibitor was added at 24 hpi, no inhibition of BV and OB
production was observed (Figs. 2C and D).There are many factors, such as viral DNA replication, viral protein
expression, and viral assembly that affect Baculovirus progeny
production. We performed a slot blot analysis and found that
inhibition of the PI3K-Akt pathway with LY294002 reduced the level
of viral DNA synthesis in AcMNPV-infected Sf9 cells from 12 to 72 hpi.
The inhibitory effect is less dramatic at 96 hpi (Fig. 3). These results
suggested that the PI3K-Akt pathway plays a positive role in viral DNA
replication.
Previous studies have shown that Baculovirus DNA replication is
dependent on early gene expression, and the regulation of Baculovirus
gene expression is highly complex (Friesen, 1997). Baculovirus gene
expression involves sequential and coordinated expression of
immediate-early, early, late, and very late genes. Following viral
entry and translocation of the viral DNA to the nucleus, immediate-
early gene expression, followed by early gene expression, occurs. After
the initiation of viral DNA replication, late genes are expressed. The
products of the early genes function to both accelerate viral DNA
replication and to prepare the host cell for viral multiplication
(Friesen, 1997). To identify the particular steps of the viral life cycle
that are regulated by this signaling pathway, we examined viral gene
expression in AcMNPV-infected cells treated with LY294002. The
Western blot analysis clearly demonstrates that both late (VP39) and
very late (POLH) gene expression were impaired (Fig. 4); however,
there was no effect on immediate-early (IE1) and early-late gene
(GP64) expression. Since Baculovirus late and very late gene expres-
sion require viral DNA replication, the delay in late and very late gene
expression is consistent with the delay in viral DNA synthesis in the
LY294002-treated Sf9 cells infected with AcMNPV (Fig. 3)
It is well documented that such a mechanism is involved in the
infection of many other viruses. For example, NS5A, a nonstructural
protein of hepatitis C virus, binds directly to the p85 subunit of PI3K
and enhances the phosphotransferase activity of the catalytic subunit
(p110) (Street et al., 2004). The latent membrane protein 1 of Epstein–
Barr virus (Dawson et al., 2003) and the middle-T antigen of polyoma
virus (Ichaso and Dilworth, 2001) were found to stimulate PI3K
activity by inducing phosphorylation, and therefore activating, Akt. In
view of the results of this study, we hypothesize that the activation of
PI3K occurs at an early stage in AcMNPV-infected Sf9 cells. Some of the
viral early gene products may modulate the PI3K-Akt signal
transduction pathway, subsequently augmenting viral DNA synthesis.
It seems that the delay in DNA synthesis would explain the delay in
late and very late genes expression, since late and very late genes
expression require DNA replication. However, the regulatory mechan-
ism by which Akt controls AcMNPV replication is unclear, and further
studies need to be done to investigate this.Materials and methods
Cells and viruses
Sf9 cells, clonal isolate 9 of IPLB-Sf21-AE cells derived from the
fall armyworm (Spodoptera frugiperda) (Vaughn et al., 1977), were
cultured at 27 °C in TNM-FH medium (Invitrogen Life Technologies)
supplemented with 10% FBS, penicillin (100 μg/ml), and streptomy-
cin (30 μg/ml) (O'Reilly et al., 1992). Virus inoculum was prepared
from AcMNPV-infected Sf9 cells at 72 hpi, and BV titers were
determined by a TCID50 end point dilution assay on Sf9 cells (O'Reilly
et al., 1992). In all experiments, cells were maintained in media
lacking serum for 24 h prior to drug treatment and/or viral infection
to eliminate the effects of growth factors in the serum. After
inoculation, cells were cultured in fresh media lacking serum and
maintained at 27 °C. Time zero was deﬁned as the time when the
virus was added to the cell culture. Unless otherwise noted, Sf9 cells
were infected with AcMNPV at a multiplicity of infection of ﬁve
plaque forming units per cell.
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The rabbit polyclonal antiphosphorylated Akt (Ser 473) antibody
and the rabbit polyclonal antitotal Akt antibody were purchased from
Santa Cruz Biotechnology. Horseradish peroxidase–conjugated anti-
rabbit and antimouse IgG were purchased from GE Healthcare. The
mouse monoclonal antiAcMNPV IE1 antibody (IE1-4B7) was kindly
provided by Dr. Linda A. Guarino (Texas A andM University, USA). The
rabbit polyclonal antiAcMNPV VP39 antibody (Li et al., 2007) and the
rabbit polyclonal antiAcMNPV polyhedrin antibody were prepared in
our laboratory. The mouse monoclonal antiGP64 antibody AcV5 was
purchased from eBioscience. The PI3K-speciﬁc inhibitor LY294002
was purchased from Sigma and dissolved in dimethyl sulfoxide. Unless
speciﬁcally noted, the treatment of cells with LY294002 was usually
performed at a concentration of 20 μM. Mock treatments were carried
out by adding demethyl sulfoxide up to 0.4% ﬁnal concentration. So,
the cells treated with 20 μM LY294002 and the control cells are ﬁlled
with the same concentration of demethyl sulfoxide. Chemicals were
added to the cultures 1 h before infection andwere present during the
entire infection.
Western blot
Sf9 cells (approximately 2×106) were grown to conﬂuence in a
35 mm dish and serum-starved for 24 h. The cells were treated with
LY294002 or mock-treated and infected with AcMNPV; 1 h pi, the cells
were maintained in serum-free media with or without LY294002. At
the indicated time points, the cells were washed with ice-cold
phosphate-buffered saline (PBS), scraped, suspended in PBS, centri-
fuged for 10 min at 3000 ×g at 4 °C, and lysed in RIPA buffer [1×PBS,
1% NP-40, 0.5% sodium deoxycholate, 0.1% (w/v) SDS] containing 1×
protease inhibitor cocktail (Roche), 1 mM phenylmethylsulfonyl
ﬂuoride, 10 mM sodium ﬂuoride, 10 mM β-glycerophosphate, and
1 mM sodium vanadate. The lysates were incubated on ice for 30 min
and centrifuged for 10min at 14000 ×g at 4 °C. The supernatants were
collected, and the protein concentration was determined using the
BCA protein assay (Pierce). Total protein (40 μg) was dissolved in
2×Laemmli SDS sample buffer, boiled for 10 min, and snap-cooled
prior to loading into an acrylamide gel. After SDS-PAGE, the proteins
were transferred onto a nitrocellulosemembrane (Whatman), and the
membrane was blocked with 5% nonfat dry milk in Tris-buffered
saline (TBS) [0.1 M Tris (pH 7.6), 0.9% NaCl] containing 0.1% Tween-20
for 1 h at room temperature. To examine phosphorylated Akt or total
Akt, a rabbit polyclonal phospho-Akt (Ser 473)-speciﬁc antibody
(1:200) or a rabbit polyclonal total Akt-speciﬁc antibody (1:200) was
applied overnight at 4 °C, respectively. A mouse monoclonal antiIE1
antibody (1:2500), a mouse monoclonal antiGP64 antibody (1:1000),
a rabbit polyclonal antiVP39 antibody (1:500), and a rabbit polyclonal
antipolyhedron antibody (1:1000) were used to examine the expres-
sion of speciﬁc viral proteins. A secondary antibody (either HRP-
conjugated antirabbit or antimouse IgG; 1:5000) was then added and
incubated at room temperature for 1 h. The blots were visualized
using an enhanced chemiluminescence reagent (ECL Advance Wes-
tern Blotting Detection Kit; GE Healthcare).
Assays for BV and OB production
To examinewhether Akt activation is involved in viral infection, BV
and OB production in AcMNPV-infected Sf9 cells treated with
LY294002 was investigated. Sf9 cells (2×106) were grown to
conﬂuence in a 35 mm dish and then serum-starved for 24 h. The
cells were treated with LY294002 or mock-treated 1 h prior to
infectionwith AcMNPV. At 1 hpi, the viral inoculumwas removed, the
cells were washed twice with media lacking serum, and fresh media
lacking serum with or without LY294002 was added. The virus-
containing supernatants were harvested and centrifuged. The BV titerof the supernatants was determined using a TCID50 end point dilution
assay on Sf9 cells. For quantiﬁcation of total produced polyhedra, 1%
(w/v) SDS was added to the cell pellets, and the cell pellets were
incubated at 37 °C for 30 min to release polyhedra (Hong et al., 2000).
The numbers of polyhedra were counted using a hemocytometer.
Slot blot analysis of viral DNA in LY294002-treated Sf9 cells
A slot blot was performed, as previously described (Wu et al.,
2006), to evaluate viral DNA replication in LY294002-treated Sf9 cells.
Brieﬂy, Sf9 cells (2×106) were grown to conﬂuence in a 35 mm dish
and then serum-starved for 24 h. The cells were treated with
LY294002 or mock-treated for 1 h prior to infection with AcMNPV.
At selected time points pi, cells were harvested by centrifugation. The
cell pellets were washed twice with PBS, resuspended in 3 ml of cell
lysis buffer, and incubated with 500 μg/ml proteinase K at 37 °C
overnight. The samples were mixed with 300 μl of 10% (w/v) SDS and
incubated at 37 °C for 1 h. DNA was extracted with phenol and
chloroform-isoamylalcohol. One quarter of each DNA sample was
resolved in 250 μl of a 0.4 M NaOH/10 mM EDTA solution and heat
treated at 100 °C for 10min. The samples were chilled on ice for 5 min,
neutralized by adding 250 μl of ice-cold 2 M ammonium acetate (pH
7.0), and then blotted onto a Nytran N nylon membrane (Schleicher
and Schuell) using a slot blot apparatus (Bio-Dot SF microﬁltration
apparatus; Bio-Rad) according to the instruction manual. The DNA
was UV-crosslinked, and the membranewas prehybridized for 0.5 h at
42 °C. The blots were then incubated with a digoxin-labeled wild-type
AcMNPV genomic DNA hybridization probe overnight at 42 °C in the
presence of 50% formamide and then were washed. The signal was
visualized using a Digoxin Detection Kit (Roche) and quantiﬁed using
Quantity One software (Bio-Rad).
Cell viability assay
Viable cell numbers were assessed by using trypan blue staining
assay. Sf9 cells were seeded in a 24-well plate at a density of 2×105
cells per well. After serum-starved for 24 h, cells were treated with 0,
5,10, 20 and 25 μMof LY294002. At 96 h, cell monolayers were stained
with 0.04% trypan blue, and total and blue cells were scored using an
inverted light microscope. For each treatment, three ﬁelds of view
were scored (Yu et al., 2008). Data were expressed as a percentage of
blue-excluded cells.
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